首页>
外国专利>
TREATMENT OF HIV-ASSOCIATED DYSMORPHIA/DYSMETABOLIC SYNDROME (HADDS) WITH OR WITHOUT LIPODYSTROPHY
TREATMENT OF HIV-ASSOCIATED DYSMORPHIA/DYSMETABOLIC SYNDROME (HADDS) WITH OR WITHOUT LIPODYSTROPHY
展开▼
机译:伴有或不伴有脂肪变性的艾滋病毒相关性肌营养不良/代谢障碍综合征(HADDS)的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
Pathological regional adipose tissue accumulation associated with HIV-associated dysmorphic/dysmetabolic syndrome (HADDS) which may occur with or without subcutaneous adipose tissue lipodystrophy (and which is also described as HIV-associated adipose redistribution syndrome or HARS and other specific medical terms), is treated by administering an effective amount of human growth hormone or other substance which binds to and initiates signalling of the hGH receptor. Alternatively, a substance which stimulates production of endogenous hGH, such as human growth hormone releasing hormone, may be administered. HADDS and related syndromes include abnormal adipose tissue accumulation in the visceral, submandibular, supraclavicular, pectoral, mammary and/or dorsocervical (buffalo hump) area, and/or with subcutaneous lipomas, with or without associated metabolic or other physiologic abnormalities.
展开▼